Wilmington Trust Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Wilmington Trust Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.45M	Sell	29,846 -9,455	-24%	-$466K	0.29%	58
2014 Q1	$2.04M	Buy	39,301 +7,240	+23%	+$385K	0.41%	43
2013 Q4	$1.7M	Sell	32,061 -1,579	-5%	-$80.4K	0.34%	49
2013 Q3	$1.56M	Buy	33,640 +172	+0.5%	+$7.55K	0.33%	49
2013 Q2	$1.49M	Buy	+33,468	New	+$1.45M	0.32%	47

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wilmington Trust Investment Management's BMY Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 24% in Q2 2014, selling an estimated $466K and leaving 29,846 shares worth $1.45M. The position accounts for 0.29% of the portfolio, ranked #58.

Wilmington Trust Investment Management first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $2.04M in Q1 2014. 1,303 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Wilmington Trust Investment Management held 29,846 shares of Bristol-Myers Squibb worth $1.45M as of Q2 2014.
Wilmington Trust Investment Management sold 9,455 Bristol-Myers Squibb shares in Q2 2014, an estimated $466K.
Bristol-Myers Squibb made up 0.29% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #58 holding.
Wilmington Trust Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
Wilmington Trust Investment Management's Bristol-Myers Squibb position peaked at $2.04M in Q1 2014.
1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.